Will kinase inhibitors have a dark side?

被引：31

作者：

Sawyers, Charles L. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA

[2] Univ Calif Los Angeles, Dept Mol Pharmacol, Los Angeles, CA USA

[3] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 03期

关键词：

D O I：

10.1056/NEJMcibr062354

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：313 / 315

页数：3

共 5 条

[1] Inhibition of TGFβ signaling in cancer therapy [J].

Arteaga, CL .

CURRENT OPINION IN GENETICS & DEVELOPMENT, 2006, 16 (01) :30-37

[2] Activation of Akt-1 (PKB-α) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion [J].

Hutchinson, JN ;

Jin, J ;

Cardiff, RD ;

Woodgett, JR ;

Muller, WJ .

CANCER RESEARCH, 2004, 64 (09) :3171-3178

[3] Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR [J].

Neshat, MS ;

Mellinghoff, IK ;

Tran, C ;

Stiles, B ;

Thomas, G ;

Petersen, R ;

Frost, P ;

Gibbons, JJ ;

Wu, H ;

Sawyers, CL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10314-10319

[4] mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt [J].

O'Reilly, KE ;

Rojo, F ;

She, QB ;

Solit, D ;

Mills, GB ;

Smith, D ;

Lane, H ;

Hofmann, F ;

Hicklin, DJ ;

Ludwig, DL ;

Baselga, J ;

Rosen, N .

CANCER RESEARCH, 2006, 66 (03) :1500-1508

[5] Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT [J].

Yoeli-Lerner, M ;

Yiu, GK ;

Rabinovitz, I ;

Erhardt, P ;

Jauliac, S ;

Toker, A .

MOLECULAR CELL, 2005, 20 (04) :539-550

← 1 →